Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commish Pick Imminent? Crawford Finally May Shed Understudy Role

This article was originally published in The Gray Sheet

Executive Summary

The White House seems to have selected FDA Acting Commissioner Lester Crawford, PhD/DVM, as its choice to fill the commissioner slot on a permanent basis

You may also be interested in...



FDA Chief Counsel Bradshaw Brings DoJ Experience, Utah Political Ties

Sheldon Bradshaw brings high-level government experience and strong political connections to the top legal position at FDA

FDA Chief Counsel Bradshaw Brings DoJ Experience, Utah Political Ties

Sheldon Bradshaw brings high-level government experience and strong political connections to the top legal position at FDA

Commissioner Nominee Crawford Must Answer “Tough Questions” – Grassley

Senate Finance Committee Chair Charles Grassley (R-Iowa) is noncommittal on FDA Acting Commissioner Lestor Crawford's nomination to fill the post on a permanent basis

Related Content

UsernamePublicRestriction

Register

MT021519

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel